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ABSTRACT
Objective: This study is aimed to evaluate the antidiabetic effect of sequentially extracted (hexane, dichloromethane [DCM], ethyl acetate, and ethanol) 
Myristica fragrans houtt (mace) through in vitro and in silico studies.
Methods: The in vitro antidiabetic effect of the sequentially extracted plant was evaluated for its alpha-amylase inhibitory activity, and the potential 
binding was studied by in silico studies using Schrödinger Maestro.
Results: All extracts showed dose-dependent alpha-amylase inhibitory effect. At concentration 500 µg/ml, all the extracts showed more than 60% 
inhibition of the alpha-amylase enzyme and the highest inhibition (81.3%) at 500 µg/ml was observed in DCM extract of mace. Potential compounds 
were identified by in silico molecular docking studies of alpha-amylase with phytocomponents from DCM extract. Among the top three compounds 
from virtual screening, induced fit docking studies revealed 2,5-bis(3,4-dimethoxyphenyl)-3, and 4-dimethyloxolane possessed better binding affinity 
when compared with the drug metformin.
Conclusion: The obtained in vitro and in silico results suggest that all extracts of M. fragrans may be used successfully for the management of diabetes 
mellitus.
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INTRODUCTION
Diabetes mellitus is one of the major concerns worldwide with more 
than 100 million affected people. It is a chronic condition characterized 
by hyperglycemia with disturbances of carbohydrate, lipid and protein 
metabolism, which results in insulin deficiency, insulin action or both. 
Irrespective of the type of diabetes (I or II), patients are required to 
control their blood glucose with insulin supplements, oral hypoglycemic 
agents, exercises, and diet [1]. The incidence of diabetes mellitus is 
markedly increased worldwide due to modern sedentary lifestyle with 
consumption of junk foods. Carbohydrates are the major constituents of 
human diet and play an important role in energy supply. Enzymes like 
alpha-amylase help in breakdown of dietary carbohydrates to glucose, 
which can be easily absorbed from intestinal lumen and transported into 
blood circulation [2]. Hence, inhibition of the enzyme alpha-amylase 
delays glucose absorption rate and maintains the blood glucose level 
in hyperglycemic patients. There are various alpha-amylase inhibitors 
available in the market such as acarbose, miglitol, and voglibose, which 
produce serious side effects like bloating and abdominal discomfort [3]. 
The major drawback of these drugs is their non-specificity in targeting 
different glucosidases. Due to prominent side effects of commercially 
available drugs have driven seeking for alternative therapies with less 
severe or no side effects. There are more than 400 traditional plants 
that are reported to have an antidiabetic effect, but only a few of them 
are investigated scientifically.
Many plants have been used as a medicine for various deceased 
conditions since ancient times in traditional medicinal systems such as 
Chinese, Indian Ayurveda, and Arabic Unani. Plants produce secondary 
metabolites that possess therapeutic properties used in the treatment 
of innumerable diseases. Secondary metabolites include tannins, 
saponins, essential oils, flavonoids, phenols, and alkaloids. Many plant 
extracts have been reported for their medicinal properties against a 
variety of diseases such as reactive oxygen species, diabetes mellitus, 
inflammation, neurodegenerative diseases, antimicrobial [4], and 
cancer. Spices and herbs have been used in the folk medicine and are 
the part of the kitchen necessities. Mace (Myristica fragrans) is an aril 
covering of the seed nutmeg, which is widely used as a flavoring agent 
in food. The essential oil of the mace contains various phytochemicals 
such as alpha-pinene, sabinene, alpha-phellandrene, alpha-terpinene, 
p-cymene, 1,8-cineole, limonene, beta-phellandrene, gamma-terpinen, 
linalool, safrole, myristicin, and elemicin [5]. Mace is also a part of 
traditional medicine used to treat indigestion, stimulating the appetite, 
nausea, to subside aches. Recent studies on mace revealed that the 
spice also has anti-inflammatory and hepato-protective properties.
In this regard, this study aims to evaluate the antidiabetic potential of 
four sequentially extracted mace through in vitro and in silico analysis.
METHODS
Chemicals and reagents
Alpha-amylase, soluble starch, 3,5-dinitrosalicylic acid (DNS), sodium 
hydroxide pellets, and sodium potassium tartrate were purchased from 
Hi-Media Laboratories Pvt. Ltd.
Plant materials and extraction
The aril part of the M. fragrans (mace) was obtained from Indian spices 
market and authenticated by Dr. N. Radhakrishnan, Assistant Professor, 
Centre of Advanced Study in Botany, University of Madras, Guindy 
Campus, Chennai. The dried mace was powdered and successively 
extracted with different organic solvents (hexane, dichloromethane 
(DCM), ethyl acetate, and ethanol) in the increasing polarity order [6]. 
Initially, 100 g of powdered mace was soaked in 300 ml of 100% hexane 
and incubated for 3 days with intermittent shaking. The extract was 
filtered using Whatman filter paper No. 1 and dried in a China dish 
covered with perforated aluminum foil. To the sediments, DCM solvent 
was added, soaked and filtered; the similar procedure was followed for 
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ethyl acetate and ethanol fractions. The extracts were stored at 4°C until 
use. The yield percentage of the extracts was 1.6, 1.4, 2.2, and 1.6 for 
hexane, DCM, ethyl acetate, and ethanol, respectively.
Alpha-amylase inhibition assay
Alpha-amylase inhibition assay was performed based on the protocol 
with minor modifications [7,8]. Different concentrations of plants 
extracts (50-500 µg/ml) were used to prepare the reaction mixture. The 
plant extracts were incubated with 0.2 ml of enzyme diluted in 200 mM 
sodium phosphate buffer at pH 6.9 for 10 minutes at room temperature 
followed by addition of 0.2 ml of 1% starch solution and incubated 
for 15 minutes at room temperature. The reaction was terminated 
by the addition of 0.5 ml of DNS (1 g of DNS dissolved in 20 ml of 2 
M NaOH, to which 30 g of sodium potassium tartrate was added and 
made up to 100 ml with distilled water). Further, the reaction mixture 
was incubated in boiling water for 15 minutes followed by immediate 
cooling on ice. Absorbance was measured using ultraviolet visible 
spectrophotometer (Shimadzu 1650pc) at 540 nm. Positive control 
was performed with drug acarbose. All the analysis was performed in 
triplicates. Percentage inhibition by the plant extracts was calculated 
according to the formula:
Inhibition (%) = Abs540 (control) – Abs540 (sample) × 100/Abs540 
(control)
Molecular docking analysis
In silico molecular docking studies were conducted with the help of 
Schrödinger Maestro [9] to identify the binding affinity of the mace 
compounds toward the enzymes. Three-dimensional structure of 
the target protein human pancreatic alpha-amylase (protein data 
bank [PDB] id: 2QV4) [10] was downloaded from PDB. Pytocomponents 
from DCM extracts were identified by gas chromatography and mass 
spectrometry and the two-dimensional structures were retrieved from 
PubChem [11] and minimized using the ligprep module in Schrödinger 
maestro software. The minimized compounds were then docked 
at the active site region of the minimized target protein using extra 
precision (XP) screening followed by an induced fit docking (IFD). 
The drug metformin was subjected to docking at the active site of the 
enzyme for comparison studies.
Statistical analysis
Data were analyzed statistically with Statistica/Macsoftware 
(Prism, USA). The experimental results were mean±standard deviation 
of three parallel measurements. Mean differences were analyzed 
statistically by running one-way analysis of variance test. p<0.05 was 
considered statistically significant when compared to relevant controls.
RESULTS
In vitro alpha-amylase inhibitory activity
The alpha-amylase inhibitory activity of the hexane, ethyl acetate, 
DCM, and ethanol extracts of mace was shown in the Fig. 1. All the four 
extracts and the positive control acarbose exhibited a dose-dependent 
alpha-amylase inhibition activity. At 500 μg/ml, DCM extract exhibited 
alpha-amylase inhibitory potential of 81.3% which was comparable with 
the inhibitory potential of acrabose (98.15%). Among four extracts, DCM 
and ethanol extracts showed 50% inhibition of the enzyme at ~200 μg/ml 
whereas, hexane and ethyl acetate showed 40% inhibition.
Molecular docking studies with human pancreatic alpha-amylase 
enzyme
To support the in vitro alpha-amylase inhibition studies and to reveal 
the binding mechanism of phytocomponents at the active site of alpha-
amylase, we have performed in silico molecular docking study.
Based on the results of XP virtual screening, top three 
compounds (2,5-bis(3,4-dimethoxyphenyl)-3,4-dimethyloxolane, 
( 2 Z ) - 2 - h y d r o x y i m i n o - N - ( 4 - m e t h o x y p h e n y l ) a c e t a m i d e , 
and N-pentafluoropropionyl-3,4-dimethoxyphenylethylamine) were 
identified and subjected to IFD. Docking score, energy, active site 
hydrogen bonds, and hydrophobic interactions of compounds were 
compared with the docking results of metformin at the active site of 
human pancreatic alpha-amylase (Table 1).
Among the three compounds that were subjected to IFD, 
2,5-bis(3,4-dimethoxyphenyl)-3,4-dimethyloxolane showed much 
better binding affinity on comparing with metformin based on 
the active site interactions, docking score, and energy. 2,5-bis(3,4-
dimethoxyphenyl)-3,4-dimethyloxolane strongly binds at the active site 
of human pancreatic alpha-amylase through the hydrogen bonds with 
Gln63, Asp197 and hydrophobic interactions with Trp58, Trp59, Tyr62, 
His101, Gly104, Val107, Leu162, Thr163, Gly164, Leu165, Arg195, 
Ala198, Glu233, Asp300, His305 amino acid residues (Fig. 2). Docking 
score, energy for metformin, and 2,5-bis(3,4-dimethoxyphenyl)-
3,4-dimethyloxolane were found to be −6.20, −28.16 kcal/mol and 
−6.523, −44.507 kcal/mol, respectively.
Fig. 2: Hydrogen bonds and hydrophobic interactions at 




Fig. 1: Inhibitory effects of four extracts of mace against alpha-
amylase enzyme. Values are expressed in mean±standard 
deviation (n=3), statistical significant test for comparison 
was done by analysis of variance followed by Dunnett’s 
t-test comparison between (a) Hexane versus acarbose, 
(b) dichloromethane versus acarbose, (c) ethyl acetate versus 
acarbose, and (d) ethanol versus acarbose. *p<0.05, **p<0.1 and 
NS: Nonsignificant
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DISCUSSION
As diabetes is a multifactorial disease leading to several complications, it 
demands a multiple therapeutic approaches. Although several therapies 
are in use, there are certain limitations such as high cost and side effects 
such as development of hypoglycemia, weight gain, gastrointestinal 
disturbances, and liver toxicity [12]. The pharmacotherapy of diabetes 
has recently undergone unprecedented expansion. However, the 
challenge is to optimize glycemic control with a minimum number 
of medication while taking into consideration the cost of the therapy, 
adverse effect profiles, ease of administration, and the urgency for blood 
sugar normalization. The search for new pharmacologically active agents 
obtained by screening natural sources such as medicinal plants or their 
extracts has led to the discovery of many clinically useful drugs that play a 
major role in the treatment of diabetes. A number of medicinal plants and 
their formulations are used for treating diabetes in folklore/Ayurvedic 
medicine system as well as in ethno medicinal practices.
This study clearly demonstrated the antidiabetic potential of the 
sequentially extracted mace through its in vitro and in silico alpha-
amylase inhibition studies. Most of the previous studies were done 
on seed part of the plant called nutmeg, which acts as a hypoglycemic 
agent by reducing the blood sugar level significantly. Our findings reveal 
that all the four extracts of mace inhibited the alpha-amylase enzyme in 
concentration dependent manner particularly DCM extract possessed 
the maximum inhibitory activity which can be comparable with 
acarbose. Plants are rich sources of therapeutic agents and are known 
to treat various human ailments over millennia. It is generally accepted 
that a cumulative synergistic relationship among the phytochemicals 
is responsible for the overall beneficial medicinal value of plants. The 
previous reports suggest that phenolic [13] and flavonols [14] are the 
compounds that modulate the enzymatic breakdown of carbohydrate 
by inhibiting alpha-amylase enzyme. Since maximum alpha-amylase 
enzyme inhibition was shown by the DCM extract, in silico molecular 
docking studies were performed for the phytocomponents present in 
the DCM extract alone. The alpha-amylase inhibitory effect of various 
phytocomponents of DCM extracts was revealed through in silico studies 
and the results suggested the high binding potential of 2,5-bis(3,4-
dimethoxyphenyl)-3,4-dimethyloxolane at the active site of alpha-
amylase enzyme when compared with other phytocomponents and 
with the control drug metformin. Natural sources and semi-synthetic 
derivatives of natural products play a crucial role in development of 
novel drugs in the modern pharmaceutical industries [15,16]. Hence, 
the compound 2,5-bis(3,4-dimethoxyphenyl)-3,4-dimethyloxolane 
present in the DCM extract can be further screened for its antidiabetic 
activity, which may serve as a potential drug candidate like acarbose 
or metformin in controlling diabetes and its associated complications.
CONCLUSION
The obtained results suggest that all the four extracts can form a good 
source of effective inhibitors of alpha-amylase enzyme and may be 
used as a potential drug in the treatment of diabetes mellitus. Further 
investigations are required for commercial usage.
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Table 1: IFD results of DCM extracts of M. fragrans houtt
Compound Docking score Energy (kcal/mol)
Metformin −6.20 −28.16
2,5-bis (3,4-dimethoxyphenyl)-3,4-dimethyloxolane −6.523 −44.507
(2Z)-2-hydroxyimino-N-(4-methoxyphenyl) acetamide −6.204 −33.022
N-pentafluoropropionyl-3,4-dimethoxyphenylethylamine −5.788 −39.931
IFD: Induced fit docking, DCM: Dichloromethane, M. fragrans: Myristica fragrans
